Rhythm Biosciences Ltd (ASX: RHY) Acquires Genetype Business
Rhythm Biosciences (ASX: RHY) has acquired Genetype assets, enhancing its oncology portfolio and positioning for immediate revenue growth.
The Hub of Australian Finance News
Rhythm Biosciences (ASX: RHY) has acquired Genetype assets, enhancing its oncology portfolio and positioning for immediate revenue growth.
Cyprium Metals (ASX:CYM) announces a non-renounceable A$3 million entitlement offer to shareholders to support growth strategies.
Ecofibre Limited (ASX:EOF) announces new loan facilities to support financial stability and operational efficiency.
Euroz Hartleys Group Limited announces the extension of its on-market buy-back programme for an additional year, now running through early 2026.
Electro Optic Systems Holdings Limited (ASX: EOS) has announced A$34 million in new orders, enhancing its defence technology offerings.
Eildon Capital Limited (ASX:EDC) announces updates on the Officer investment and joint venture agreements following personnel changes.
FBR Limited successfully completes its US Demonstration Program, paving the way for an exclusive joint venture for construction robots.
Mach7 Technologies Limited (ASX:M7T) announces the signing of A$4.6M in new contracts to enhance its PACS solutions and future revenue growth.
MetalsTech Limited (ASX:MTC) announces positive results from the updated Scoping Study for the Sturec Gold Mine, revealing strong economic and technical viability.
Tinybeans Group Limited (ASX:TNY) announces significant board changes, positioning for growth with a new leadership structure.